Helius Medical Technologies is trading 5.9% down now at $2.08 after September 1, 2026 risk-off trading pressured U.S. equities amid Middle East tensions, higher oil prices, and rising global bond yields.
- The Nasdaq is down about 1%, while the S&P 500 is down more than 0.5%.
- No fresh company-specific catalyst was identified; the August 14 quarterly report remains the latest notable company news.